About Careers MedBlog Contact us

Head and Neck Cancer can be Treated by Herpes Virus

by Kathy Jones on August 2, 2010 at 8:49 PM
Font : A-A+

 Head and Neck Cancer can be Treated by Herpes Virus

Genetically engineered herpes virus can help successfully cure patients with head and neck cancer, doctors have found.

A London hospital trial of 17 patients has shown that use of the virus along with chemotherapy and radiotherapy helped kill the tumours in most patients.


Study leader Dr Kevin Harrington, of Institute of Cancer Research in London, said current treatments were effective if the cancer was diagnosed early.

The herpes virus is genetically modified in such a way that it grows inside tumour cells but cannot infect normal healthy cells.

Once there it has a triple effect - it multiplies, killing tumour cells as it does so, it is engineered to produce a human protein that activates the immune system and it also makes a viral protein that acts as a red flag to immune cells.

In the 17 patients injected with the virus, in addition to their standard treatment, 93 percent showed no trace of cancer after their tumour had been surgically removed.

More than two years later, 82 percent of patients had not succumbed to the disease.

According to Clinical Cancer Research only two of 13 patients given the virus treatment at a high dose relapsed.

"Around 35 to 55 percent of patients given the standard chemotherapy and radiotherapy treatment typically relapse within two years, so these results compare very favorably," the BBC quoted Harrington as saying.

Dr Alison Ross of Cancer Research UK said it would be some time before the treatment could be used in patients, as it still needed to be tested directly against standard treatment.

But she added: "This small study highlights the potential of using genetically modified viruses as a weapon to fight cancer."

Source: ANI


Recommended Reading

Latest Cancer News

 Myelofibrosis: New Drugs to Revolutionize Treatment
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
 Blood Vessels Can Kill Cancer Cells and Stop Breast Cancer Spread
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
 Weed Killer Agent Orange May Increase the Risk of Blood Cancer Among Veterans
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Two Years: Optimal Duration of Immunotherapy in Advanced Lung Cancer
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
Hope for Lethal Brain Tumors: Targeted Therapy Delays Glioma Progression
A ray of hope for glioma patients as targeted therapy boosts treatment duration.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Head and Neck Cancer can be Treated by Herpes Virus Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests